We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04985721
Brief Title: A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (IMPARP-HRD)

First Submitted : June 28, 2021
First Submitted that Met QC Criteria : July 29, 2021
First Posted : August 2, 2021

Last Update Submitted that Met QC Criteria : March 3, 2022
Last Update Posted : March 4, 2022